Australian healthcare stocks fall after Trump gives details on pharma tariffs

Australian healthcare stocks .AXHJ fall as much as 1.4% - biggest intraday pct decline since June 23

U.S. President Donald Trump says he will announce tariffs on pharmaceutical imports potentially at the end of July, starting with a 'low tariff' to give companies time to move their manufacturing units to the U.S. before imposing a 'very high tariff' in a year or so

Australian pharmaceutical firms benefit significantly from U.S. sales

Sector giant CSL CSL.AX falls 1.8% while Telix Pharmaceuticals TLX.AX down 0.7%

Sub-index down 5.8% YTD vs 4.9% in broader benchmark .AXJO